Protagenic Therapeutics, Inc.
PTIX
$0.218
-$0.0001-0.05%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 74.13% | 14.19% | -61.85% | -40.24% | -23.07% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -87.90% | -17.42% | 909.77% | -69.44% | 38.33% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 32.35% | 3.93% | -44.53% | -41.24% | -21.89% |
|
|||||
Total Current Assets | 32.35% | 3.93% | -44.53% | -41.24% | -21.89% |
Net Property, Plant & Equipment | -14.72% | -12.83% | -11.37% | -10.14% | 120.18% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 29.68% | 2.81% | -43.10% | -40.36% | -20.42% |
|
|||||
Total Accounts Payable | -5.16% | 16.15% | -14.22% | -4.22% | -53.26% |
Total Accrued Expenses | 23.37% | 17.14% | 72.38% | -37.75% | -12.21% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 19.45% | 17.00% | 51.22% | -31.92% | -48.81% |
|
|||||
Total Current Liabilities | 19.45% | 17.00% | 51.22% | -31.92% | -48.81% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 19.45% | 17.00% | 51.22% | -31.92% | -48.81% |
|
|||||
Common Stock & APIC | 5.19% | 1.62% | 0.89% | 0.47% | 2.03% |
Retained Earnings | -4.47% | -1.88% | -4.94% | -5.60% | -5.76% |
Treasury Stock & Other | 0.23% | 0.00% | -50.00% | 23.52% | 81.63% |
Total Common Equity | 40.92% | -9.27% | -62.84% | -41.86% | -11.67% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 40.92% | -9.27% | -62.84% | -41.86% | -11.67% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 40.92% | -9.27% | -62.84% | -41.86% | -11.67% |
|